Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
Back to event

The Way the FDA and DEA Ban Drugs Is Unaccountable and Arbitrary

By Ryan Curtis · Sep 29, 2026, 10:40 AM CDT

Read full article at Reason
Since the beginning of the war on drugs over 55 years ago, the federal government has been classifying and regulating drugs through a "scheduling" system. A new report from the Government Accountability Office (GAO) reveals just how arbitrary scheduling decisions made by the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) can be. In the United States, the primary law r

Excerpt shown under fair-use limits. Full text remains with the original publisher.

People in this coverage

Explore their history and attributable record. Being mentioned does not imply endorsement.

Layer 1 · Claims & fact checks

AI analysis

Layer 2 · Biblical perspective

Biblical interpretation
INSUFFICIENT CONTEXT
Read the biblical analysis

Layer 3 · Reporting analysis

AI analysis

Loaded LanguageThe phrase emphasizes negligence and frames the agency as incompetent.

Appeal to AuthorityThe article relies on the GAO’s authority to legitimize its critique without presenting counter‑views.

Contrast FramingThe comparison is used to argue that marijuana is less harmful, supporting the claim that scheduling is arbitrary.

Speculative AssertionThe article speculates about internal decision‑making without evidence, introducing bias.

Narrative FramingFrames drug policy as uniformly negative, ignoring nuanced outcomes or successes.

Context

AI analysis

Missing context

The piece omits details about any existing internal guidance documents, the role of the DEA’s and FDA’s scientific advisory committees, and the legal standards that agencies must follow under the CSA. It also does not mention any prior GAO findings on the same issue or how the agencies have responded to the report’s conclusions.

Important context

The GAO report focuses on the lack of formal, written policies for scheduling decisions, but it does not assess the quality of informal practices, expert consultations, or case‑by‑case scientific evaluations that may still guide DEA and FDA actions. Additionally, the article does not provide the GAO’s recommendations or any response from the agencies, which would be relevant for understanding potential reforms.

Opinion vs. reporting

AI analysis

The article mixes reporting of GAO findings (e.g., direct quotes about the absence of policies) with strong editorial commentary (e.g., describing the process as “arbitrary,” “made‑up,” and attributing motives such as “meddlesome”). The factual sections are presented alongside opinionated language, making the overall tone more persuasive than neutral.